Ann Mullally
13PUBLICATIONS
67CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Feb 24, 2026
Risk stratification of patients with TP53-mutated myeloproliferative neoplasms.Benjamin Rolles, Cilomar Martins de Oliveira Filho, Nathan Fergusson
|Aug 26, 2025
Novel strategies targeting mutant calreticulin in essential thrombocythemia and myelofibrosis.Gabriel S Salzman, Ann Mullally
|Jan 08, 2025
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications.Mifra Faiz, Merle Riedemann, Jonas S Jutzi
|Dec 19, 2022
Biology and therapeutic targeting of molecular mechanisms in MPNs.Joan How, Jacqueline S Garcia, Ann Mullally
|Dec 06, 2022
CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response.Jonas S Jutzi, Anna E Marneth, María José Jiménez-Santos
|Jun 28, 2022
Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs.Jonas S Jutzi, Anna E Marneth, Michele Ciboddo
Pageof 3
Frequent Collaborators
4 joint publications
Jonas S Jutzi
4 joint publications
Anna E Marneth
2 joint publications
Fátima Al-Shahrour
2 joint publications
Baransel Kamaz
2 joint publications
Trine Alma Knudsen
2 joint publications
Vibe Skov
2 joint publications
Dennis Lund Hansen
2 joint publications
Benjamin Rolles
2 joint publications
R Coleman Lindsley
2 joint publications
Hans Hasselbalch
